Acadia Healthcare price target lowered to $17 from $22 at Cantor Fitzgerald

Cantor Fitzgerald lowered the firm’s price target on Acadia Healthcare (ACHC) to $17 from $22 and keeps a Neutral rating on the shares. Acadia cut its 2025 EBITDA guidance by $49M to $601-611M, marking a total $94M reduction since the initial forecast, primarily due to professional and general liability expenses, the analyst tells investors in a research note. With limited near-term recovery catalysts and modest 2026 PLGL tailwinds of $6-16M, the outlook remains cautious, the firm says.